Albayrak, Y., & Hashimoto, K. (2013). Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients with Schizophrenia: Report of Three Cases. Korean Neuropsychiatric Association.
Stile di citazione ChicagoAlbayrak, Yakup, e Kenji Hashimoto. Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients With Schizophrenia: Report of Three Cases. Korean Neuropsychiatric Association, 2013.
Citazione MLAAlbayrak, Yakup, e Kenji Hashimoto. Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients With Schizophrenia: Report of Three Cases. Korean Neuropsychiatric Association, 2013.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.